ResApp Health Limited

ASX:RAP Stock Report

Market Cap: AU$176.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ResApp Health Management

Management criteria checks 4/4

Key information

Tony Keating

Chief executive officer

AU$318.8k

Total compensation

CEO salary percentage80.2%
CEO tenure7.2yrs
CEO ownership1.2%
Management average tenure4.4yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Dec 31
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Aug 26
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

May 08
Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Feb 25
Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

Dec 23
Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Tony Keating's remuneration changed compared to ResApp Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022AU$319kAU$256k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$7m

Jun 30 2021AU$358kAU$256k

-AU$7m

Mar 31 2021n/an/a

-AU$7m

Dec 31 2020n/an/a

-AU$8m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$449kAU$256k

-AU$8m

Mar 31 2020n/an/a

-AU$7m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$290kAU$256k

-AU$5m

Mar 31 2019n/an/a

-AU$6m

Dec 31 2018n/an/a

-AU$7m

Sep 30 2018n/an/a

-AU$7m

Jun 30 2018AU$296kAU$256k

-AU$7m

Mar 31 2018n/an/a

-AU$6m

Dec 31 2017n/an/a

-AU$6m

Sep 30 2017n/an/a

-AU$8m

Jun 30 2017AU$1mAU$256k

-AU$10m

Mar 31 2017n/an/a

-AU$10m

Dec 31 2016n/an/a

-AU$9m

Sep 30 2016n/an/a

-AU$6m

Jun 30 2016AU$537kAU$189k

-AU$3m

Compensation vs Market: Tony's total compensation ($USD214.17K) is about average for companies of similar size in the Australian market ($USD283.12K).

Compensation vs Earnings: Tony's compensation has been consistent with company performance over the past year.

CEO

Tony Keating

7.2yrs

Tenure

AU$318,770

Compensation

Dr. Anthony James Keating, also known as Tony, has been Chief Executive Officer and Managing Director of ResApp Health Limited since July 2, 2015. Dr. Keating served as a Director of Commercial Engagement...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Al Lunar
Vice President of Finance1.7yrsno datano data
Scott Savage
Vice President of Technology & Productno datano datano data
Nicki Farley
Company Secretary9.8yrsno datano data
Clas Källander
Founder and Director of R&D of Cavidi ABno dataAU$108.72kno data
Mike Connell
VP of Commercialno datano datano data
Paul Porter
Scientific Advisorno datano datano data

4.4yrs

Average Tenure

Experienced Management: RAP's management team is considered experienced (4.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Paul Porter
Scientific Advisorno datano datano data
Michael Stein
Non-Executive Director2.4yrsAU$55.00kno data
Roger Aston
Non-Executive Chairman7.2yrsAU$90.00k0.034%
A$ 59.4k
Joseph Kvedar
Member of Industry Advisory Board3.3yrsno datano data
Christopher Ntoumenopoulos
Non-Executive Director7.7yrsAU$55.00k0.058%
A$ 102.5k
Naomi Fried
Member of Industry Advisory Board3.3yrsno datano data
Philip Currie
Member of Scientific Advisory Board5.1yrsno datano data
Scott Claxton
Member of Scientific Advisory Board3.7yrsno datano data
Elizabeth Talbot
Member of Scientific Advisory Boardless than a yearno datano data
Catherine Bennett
Member of Scientific Advisory Boardless than a yearno datano data

3.3yrs

Average Tenure

58yo

Average Age

Experienced Board: RAP's board of directors are considered experienced (3.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.